Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-2,200
Closed -$272K 4975
2021
Q3
$272K Buy
+2,200
New +$283K ﹤0.01% 3742
2021
Q1
Sell
-2,000
Closed -$204K 4312
2020
Q4
$204K Buy
+2,000
New +$188K ﹤0.01% 3109
2020
Q1
Sell
-4,900
Closed -$386K 3915
2019
Q4
$386K Sell
4,900
-300
-6% -$23.4K ﹤0.01% 3000
2019
Q3
$414K Buy
+5,200
New +$409K ﹤0.01% 2705
2019
Q2
Sell
-2,700
Closed -$213K 3721
2019
Q1
$213K Buy
+2,700
New +$197K ﹤0.01% 2789
2018
Q4
Sell
-2,800
Closed -$224K 3610
2018
Q3
$224K Buy
+2,800
New +$209K ﹤0.01% 2944

Other funds holding XYL

John Overdeck's XYL Position: Q2 2026 in Review

John Overdeck increased its Xylem (XYL) stake by 53% in Q2 2026, buying an estimated $8.69M and bringing the position to 216,869 shares worth $25.6M. The position accounts for 0.02% of the portfolio, ranked #905.

John Overdeck first reported a position in XYL in Q2 2013 and has held it in 31 quarters since. The position peaked at $134M in Q2 2023. 1,090 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • John Overdeck held 216,869 shares of Xylem worth $25.6M as of Q2 2026.
  • John Overdeck bought 75,318 Xylem shares in Q2 2026, an estimated $8.69M.
  • Xylem made up 0.02% of John Overdeck's portfolio in Q2 2026, its #905 holding.
  • John Overdeck first reported a position in Xylem in Q2 2013 and has held it in 31 quarters since.
  • John Overdeck's Xylem position peaked at $134M in Q2 2023.
  • 1,090 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.